Cardiovascular Research

Pathobiology and Clinical Impact of Reperfusion Injury.

Authors: Y Birnbaum|||J Leor|||RA Kloner

Affiliations: + Expand

Abstract

Reperfusion injury refers to cellular death or dysfunction caused by restoration of blood flow to previously alchemic tissue. This should be differentiated from the normal reparative processes that follow an ischemic insult. Four types of reperfusion injury have been described in the literature: (1) lethal reperfusion injury, (2) nonlethal reperfusion injury, (myocardial stunning), (3) reperfusion arrhythmias, and (4) vascular injury (including the "no-reflow" phenomenon). There is continued debate whether reperfusion itself is capable of killing viable myocytes, which otherwise would have survived the ischemic insult. However, there is firm evidence for the existence of myocardial stunning following various ischemic syndromes, including reperfusion therapy for acute myocardial infarction, unstable angina pectoris, vasospastic angina, effort-induced ischemia, coronary artery bypass surgery, and cardiac transplantation. Reperfusion arrhythmia is more common after short ischemic episodes than after long ischemic periods. Thus, while reperfusion arrhythmias in the setting of acute myocardial infarction are relatively rare, reperfusion arrhythmias may be an important cause of sudden death. The "no-reflow" phenomenon has been described following reperfusion in patients with acute myocardial infarction. Three major components have been proposed as mediators of reperfusion injury: (1) oxygen free radicals, (2) the complement system, and (3) neutrophils. Numerous experimental studies have shown short-term benefit by blocking various stages of the postischemic inflammatory response. Oxygen free radicals scavengers, complement inhibition, leukocyte depletion, and the use of antibodies against various adhesion molecules have shown a reduction of infarct size in many ischemic/reperfusion experimental models. However, many of these agents failed to show a benefit in the clinical setting. Moreover, the long-term benefit of such intervention is still unknown.

---

Reference List

J Am Coll Cardiol. 1987 Apr;9(4):898-902|||Am J Cardiol. 1983 Jul;52(1):19-25|||Ann Thorac Surg. 1994 Jul;58(1):170-5|||Circulation. 1994 May;89(5):1982-91|||J Biol Chem. 1969 Nov 25;244(22):6049-55|||Am J Cardiol. 1993 May 1;71(12):1045-51|||Am J Physiol. 1988 Nov;255(5 Pt 2):H1188-98|||J Clin Invest. 1994 Mar;93(3):1140-8|||Ann Thorac Surg. 1988 Dec;46(6):619-24|||J Clin Invest. 1993 Sep;92(3):1504-16|||J Am Coll Cardiol. 1990 May;15(6):1261-9|||Eur Heart J. 1993 Jul;14 Suppl A:14-21|||Circulation. 1989 Dec;80(6):1846-61|||Am Heart J. 1994 May;127(5):1241-50|||Biomed Pharmacother. 1989;43(2):87-92|||J Cell Biol. 1991 Feb;112(4):749-59|||Am J Cardiol. 1991 Aug 1;68(4):329-34|||Am J Physiol. 1987 Sep;253(3 Pt 2):H709-11|||Circ Res. 1989 Sep;65(3):607-22|||Circulation. 1993 Feb;87(2):526-35|||Ann Thorac Surg. 1991 Jul;52(1):127-30|||Circulation. 1989 Nov;80(5):1115-27|||Am J Med. 1991 Sep 30;91(3C):86S-88S|||J Mol Cell Cardiol. 1983 Dec;15(12):859-62|||Hum Pathol. 1985 Oct;16(10):973-8|||Surgery. 1988 Aug;104(2):272-9|||Cardiovasc Res. 1994 Mar;28(3):422; discussion 424-32|||Basic Res Cardiol. 1993 Mar-Apr;88(2):150-4|||Int J Cardiol. 1994 Apr;44(2):123-9|||J Mol Cell Cardiol. 1989 Mar;21(3):263-7|||J Clin Invest. 1974 Dec;54(6):1496-508|||Circ Res. 1988 Mar;62(3):572-84|||Lancet. 1990 Jul 21;336(8708):143-5|||Circulation. 1990 Sep;82(3):723-38|||N Engl J Med. 1992 May 28;326(22):1451-5|||Circulation. 1995 Mar 15;91(6):1872-85|||Am Heart J. 1981 Jan;101(1):59-66|||Cardiovasc Drugs Ther. 1991 Mar;5 Suppl 2:297-300|||Cardiovasc Clin. 1990;20(2):23-56|||Br J Exp Pathol. 1980 Jun;61(3):242-55|||Circulation. 1985 Apr;71(4):699-708|||Am J Cardiol. 1994 Mar 10;73(6):2B-7B|||J Am Coll Cardiol. 1994 Dec;24(7):1591-601|||Circulation. 1984 Sep;70(3):513-21|||Cardiovasc Res. 1994 Sep;28(9):1301-11|||J Clin Invest. 1994 Oct;94(4):1621-8|||Eur J Immunol. 1990 May;20(5):999-1005|||Circulation. 1992 May;85(5):1699-705|||Circulation. 1989 Dec;80(6):1816-27|||Basic Res Cardiol. 1993 Sep-Oct;88(5):513-23|||Circulation. 1983 Jun;67(6):1290-5|||N Engl J Med. 1985 Jan 17;312(3):159-63|||Free Radic Biol Med. 1988;4(1):9-14|||Am J Med. 1991 Sep 30;91(3C):95S-105S|||Eur Heart J. 1994 Feb;15(2):179-83|||J Am Coll Cardiol. 1995 Mar 1;25(3):781-8|||Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1631-2|||Circulation. 1993 Feb;87(2):355-62|||J Clin Invest. 1983 Jul;72(1):84-95|||Cardiovasc Res. 1994 Mar;28(3):289-94|||Am J Cardiol. 1986 Sep 15;58(7):647-9|||Can J Cardiol. 1992 Apr;8(3):280-6|||Circulation. 1994 Jul;90(1):114-20|||Circulation. 1980 Apr;61(4):759-68|||Am J Cardiol. 1993 Mar 15;71(8):745-9|||Am Heart J. 1983 Feb;105(2):323-5|||Am Heart J. 1984 Sep;108(3 Pt 1):440-6|||J Am Coll Cardiol. 1993 Feb;21(2):537-45|||Circulation. 1990 Jan;81(1):201-11|||Eur J Cardiothorac Surg. 1990;4(10):538-42|||J Clin Invest. 1993 Jun;91(6):2620-9|||J Am Coll Cardiol. 1991 Oct;18(4):911-8|||Clin Cardiol. 1993 Apr;16(4 Suppl 1):I19-26|||Biochem J. 1980 Nov 1;191(2):421-7|||Circulation. 1991 Oct;84(4):1758-72|||J Am Coll Cardiol. 1994 Sep;24(3):624-30|||Lancet. 1990 Mar 31;335(8692):741-3|||Circulation. 1993 Oct;88(4 Pt 1):1779-87|||FEBS Lett. 1975 Jul 1;54(3):311-4|||Circ Res. 1987 Jul;61(1):50-4|||J Thorac Cardiovasc Surg. 1994 Dec;108(6):1125-31|||J Thorac Cardiovasc Surg. 1994 Jan;107(1):248-56|||Biochem J. 1973 Jul;134(3):707-16|||N Engl J Med. 1983 Jun 2;308(22):1312-8|||Am Heart J. 1991 Jan;121(1 Pt 1):20-4|||Am J Pathol. 1983 Apr;111(1):98-111|||J Mol Cell Cardiol. 1988 Dec;20(12):1163-78|||Circulation. 1976 Mar;53(3 Suppl):I204-6|||Am Heart J. 1987 Feb;113(2 Pt 1):383-5|||Science. 1990 Jul 13;249(4965):146-51|||Am J Cardiol. 1991 Aug 1;68(4):392-5|||Jpn Circ J. 1979 May;43(5):395-401|||Cardiovasc Res. 1993 Nov;27(11):1906|||J Heart Lung Transplant. 1992 Nov-Dec;11(6):1082-92|||Am Heart J. 1991 Feb;121(2 Pt 1):593-5|||J Am Coll Cardiol. 1983 Dec;2(6):1085-91|||J Thorac Cardiovasc Surg. 1994 Jan;107(1):242-7|||J Mol Cell Cardiol. 1985 Oct;17(10):937-45|||Ann Thorac Surg. 1994 Nov;58(5):1427-32|||Annu Rev Pharmacol Toxicol. 1994;34:17-40|||Am J Med. 1991 Sep 30;91(3C):79S-85S|||J Am Coll Cardiol. 1985 Mar;5(3):593-8|||Am J Cardiol. 1983 Sep 1;52(5):610-4|||Am J Cardiol. 1981 Sep;48(3):403-9|||J Thorac Cardiovasc Surg. 1979 Apr;77(4):504-10|||Acta Physiol Scand Suppl. 1986;548:39-46|||Cardiovasc Res. 1994 Apr;28(4):437-44|||Am J Cardiol. 1990 Apr 15;65(15):953-61|||Circulation. 1994 Jun;89(6):2736-46|||Circulation. 1982 Dec;66(6):1146-9|||Eur Heart J. 1991 Dec;12 Suppl G:16-9|||J Reconstr Microsurg. 1989 Jan;5(1):79-84|||Annu Rev Pharmacol Toxicol. 1993;33:71-90|||J Clin Invest. 1987 Dec;80(6):1728-34|||Circulation. 1993 Aug;88(2):649-58|||Cardiovasc Drugs Ther. 1991 Mar;5 Suppl 2:249-68|||J Am Coll Cardiol. 1994 Aug;24(2):370-7